Polysubstance Use: The Exception or the Rule?-View Presentation

Video Transcription

Video Summary

The webinar, led by Dr. John Renner and Dr. Stephen Wyatt, focused on polysubstance use and argued that it is often the rule rather than the exception, especially among vulnerable populations. Dr. Wyatt defined polysubstance use as taking more than one drug, intentionally or unintentionally, and emphasized that combining substances can produce stronger, more unpredictable, and potentially fatal effects.<br /><br />He reviewed emergency department data showing common and dangerous combinations, especially stimulants with cannabis, opioids with stimulants, and alcohol with opioids or other depressants. Alcohol was highlighted as a frequently overlooked contributor to overdose risk and drug poisonings. Dr. Wyatt also discussed rising overdose deaths involving fentanyl, stimulants, and other substances, and noted that heroin has largely declined in favor of fentanyl due to potency and ease of transport.<br /><br />The presentation covered major risks associated with polysubstance use, including overdose, psychosis, relapse, suicide risk, and long-term cognitive and developmental harm. Particular attention was given to adolescents, prenatal exposure, trauma, and co-occurring mental health disorders such as depression, anxiety, bipolar disorder, and histories of abuse.<br /><br />Treatment themes included routine screening for multiple substances, integrated mental health care, trauma-informed treatment, naloxone distribution, and reducing stigma. Dr. Wyatt also discussed emerging evidence for GLP-1 medications, disulfiram, and the importance of addressing secondary substance use rather than focusing only on a primary drug. The session concluded with a Q&A on fentanyl-stimulant combinations, alcohol with buprenorphine, heroin’s decline, youth initiation patterns, and the potential role of GLP-1s in treating multiple substance use disorders.

Keywords

polysubstance use

overdose risk

fentanyl

stimulants

alcohol

naloxone

trauma-informed care

mental health disorders

adolescent substance use

GLP-1 medications